Source comparison
Best SS-31 Dosage Cellular Energy 2026: Protocol Comparison
Mitochondrial Disorder Support 0.25–0.3 Morning, fasted Barth syndrome, MELAS, chronic fatigue with confirmed mito dysfunction 4–8 weeks for measurable VO2 or lactate ratio changes Clinically validated. Lowest effective threshold for cardiolipin stabilisation
This comparison does not assign a generated winner or score.
- Mitochondrial Disorder Support
- 0.25–0.3
- Morning, fasted
- Barth syndrome, MELAS, chronic fatigue with confirmed mito dysfunction
- 4–8 weeks for measurable VO2 or lactate ratio changes
- Clinically validated. Lowest effective threshold for cardiolipin stabilisation
- Performance and Recovery
- 0.35–0.5
- 60–90 min pre-training
- Athletes targeting post-exercise ATP recovery, reduced ROS
- 2–4 weeks for subjective recovery improvement, 6–8 weeks for performance markers
- Requires higher dose due to baseline mitochondrial health. Benefits conditional on training stimulus
- Cognitive Energy
- 0.3–0.4
- Morning or pre-cognitive work
- Age-related cognitive decline, brain fog, neurodegenerative risk reduction
- 4–6 weeks for sustained attention or processing speed changes
- Emerging evidence. Mechanisms plausible (neuronal mitochondria are high-energy consumers) but fewer RCTs than cardiac applications
- Anti-Aging / Longevity
- 0.25–0.35
- Healthy individuals targeting mitochondrial maintenance and oxidative stress reduction
- 8–12 weeks for biomarker shifts (8-OHdG, mtDNA copy number)
- Preventive use. Requires long-term commitment and biomarker tracking to justify cost